SI1812422T1 - Kristalna oblika irbesartana - Google Patents

Kristalna oblika irbesartana

Info

Publication number
SI1812422T1
SI1812422T1 SI200531839T SI200531839T SI1812422T1 SI 1812422 T1 SI1812422 T1 SI 1812422T1 SI 200531839 T SI200531839 T SI 200531839T SI 200531839 T SI200531839 T SI 200531839T SI 1812422 T1 SI1812422 T1 SI 1812422T1
Authority
SI
Slovenia
Prior art keywords
irbesartan
polymorph form
polymorph
Prior art date
Application number
SI200531839T
Other languages
English (en)
Inventor
Ljubomir Antoncic
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI1812422T1 publication Critical patent/SI1812422T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200531839T 2004-11-11 2005-11-09 Kristalna oblika irbesartana SI1812422T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200400308 2004-11-11
PCT/EP2005/011982 WO2006050923A1 (en) 2004-11-11 2005-11-09 Polymorph form of irbesartan
EP05802257.5A EP1812422B1 (en) 2004-11-11 2005-11-09 Polymorph form of irbesartan

Publications (1)

Publication Number Publication Date
SI1812422T1 true SI1812422T1 (sl) 2014-05-30

Family

ID=36121341

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531839T SI1812422T1 (sl) 2004-11-11 2005-11-09 Kristalna oblika irbesartana

Country Status (5)

Country Link
US (1) US20090208573A1 (sl)
EP (1) EP1812422B1 (sl)
ES (1) ES2454197T3 (sl)
SI (1) SI1812422T1 (sl)
WO (1) WO2006050923A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007099555A2 (en) * 2006-02-17 2007-09-07 Alembic Limited Pharmaceutical tablet compositions containing irbesartan
WO2008018843A1 (en) * 2006-08-08 2008-02-14 Ulkar Kimya Sanayi Ve Ticaret As Process for producing useful salts form of biphenyl-tetrazole compounds
WO2008125388A1 (en) * 2007-04-17 2008-10-23 Ratiopharm Gmbh Pharmaceutical compositions comprising irbesartan
CN113648281B (zh) * 2021-09-24 2023-01-17 宁夏医科大学 一种多晶型厄贝沙坦纳米混悬液及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725987B1 (fr) 1994-10-19 1997-01-10 Sanofi Sa Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
FR2780403B3 (fr) 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
WO2003050110A1 (en) * 2001-12-10 2003-06-19 Dr. Reddy's Laboratories Ltd. Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
DE10301371A1 (de) * 2003-01-16 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Kombination zur Prophylaxe oder Therapie von kardiovaskulären, kardiopulmonalen, pulmonalen oder renalen Krankheiten
WO2004089938A1 (en) * 2003-04-07 2004-10-21 Hetero Drugs Limited A novel crystalline form of irbesartan
WO2005051943A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Processes for the preparation of highly pure irbesartan
WO2006001026A1 (en) 2004-06-23 2006-01-05 Hetero Drugs Limited Irbesartan polymorphs

Also Published As

Publication number Publication date
US20090208573A1 (en) 2009-08-20
EP1812422A1 (en) 2007-08-01
WO2006050923A1 (en) 2006-05-18
EP1812422B1 (en) 2013-12-25
ES2454197T3 (es) 2014-04-09

Similar Documents

Publication Publication Date Title
PT1778618E (pt) Síntese de trietilenotetraminas
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
IL181587A0 (en) Production of ??-abeta
IL216401A0 (en) Sustained release of antinfectives
ZA200706345B (en) Amino-pyridines as inhibitors of ß-secretase
EP1756092A4 (en) NEW INHIBITORS OF RHO-KINASEN
ZA200802585B (en) Pyridopyrimidinone inhibitors of Pl3Kα
IL190292A0 (en) PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
IL187301A0 (en) Methods of synthesizing 6 - alkylaminoquinoline derivatives
IL209964A0 (en) Use of organic compounds
IL185757A0 (en) Methods of decreasing calcifcation
PL1931842T3 (pl) Zespół profili
EP1711484A4 (en) SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
EP1804582A4 (en) POLYMORPH SHAPES OF TADALAFIL
IL181185A0 (en) Novel polymorphs of azabicyclohexane
GB0504314D0 (en) Novel polymorph
ZA200703495B (en) Process for the preparation of irbesartan hydrochloride
EP2057144A4 (en) NEW POLYMORPHIC FROM RIMONABANT
SI1812422T1 (sl) Kristalna oblika irbesartana
GB0618703D0 (en) Synthesis of leikotriene compounds
ZA200803678B (en) An improved process for preparation of Irbesartan
ZA200703630B (en) Polymorphs of sarsapogenin
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
IL186143A0 (en) Pro-drugs of n-thiazol-2yl-benzamide derivatives
AU158365S (en) Set of fins for surfcraft